Jump to content

Gangliosides (like GM1) - how to measure? Their sialic acid may be anti-inflammatory (and may be related to Glycanage). Is higher Glycanage predictive of reduced ganglioside synthesis?


Recommended Posts

https://www.genecards.org/cgi-bin/carddisp.pl?gene=ST6GAL1

 

https://www.frontiersin.org/articles/10.3389/fnins.2020.572965/full

https://glycanage.com/glycanhub/podcast/season-1/glycans-and-neurodegenerative-diseases-a-new-perspective-on-alzheimers-with-prof-ronald-schnaar

Quote

During brain development, the ganglioside pattern changes from the prevalence of the simple gangliosides GM3 and GD3 to more complex ones such as GD1a and GT1b [66] (for structures, see Figures Figures77 and and11).11). Ganglioside content and composition of the brain change also during aging: for example, the amount of lipid-bound sialic acid decreased from 1070 μg/g wet weight in a 25-year-old healthy proband to 380 μg/g wet weight in a 85-year-old individual. Despite this, the concentrations of GQ1b, GT1b, and GD1b increase with age at the expense of GM1 and GD1a

GM1 = 4 chain, GM3 = 1chainimage.png.c71977f2cdca5ed2b595acc18a019ba1.png

https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-021-02374-x

Edited by InquilineKea
Link to comment
Share on other sites

  • Alex K Chen changed the title to Gangliosides (like GM1) - how to measure? Their sialic acid may be anti-inflammatory (and may be related to Glycanage). Is higher Glycanage predictive of reduced ganglioside synthesis?

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...